3 products were found matching "138926-19-9"!

No results were found for the filter!
Ibandronate sodium monohydrate
Ibandronate sodium monohydrate

Item number: TGM-T6539-100mg

Description: Ibandronate sodium monohydrate (BM-210955) is a highly potent nitrogen-containing bisphosphonate used for the treatment of osteoporosis. Target: Others, Apoptosis. Smiles: O.[Na+].CCCCCN(C)CCC(O)(P(O)(O)=O)P(O)([O-])=O. References: Morgan C, et al. Microvasc Res, 2009, 78(3), 453-458.
Keywords: RPR-102289A, BM-21.0955, BM-210955, Bondronat monohydrate, Ibandronate sodium, Boniva monohydrate
Application: Targets farnesyl diphosphate synthase [EC:2.5.1.1 2.5.1.10] (FDPS)
CAS 138926-19-9
MW: 359.23 D
From 31.00€ *
Review
Ibandronate (sodium hydrate)
Ibandronate (sodium hydrate)

Item number: Cay21361-25

Ibandronate is a bisphosphonate that has been used in formulations for the treatment of osteoporosis. It binds to hydroxyapatite crystals with an affinity constant of 2.36 µM, inhibiting their growth and bone resorption.Formal Name: P,P'-[1-hydroxy-3-(methylpentylamino)propylidene]bis-phosphonic acid, monosodium...
Keywords: P,P'-[1-hydroxy-3-(methylpentylamino)propylidene]bis-phosphonic acid, monosodium salt, monohydrate
Application: Bisphosphonate, osteoporosis agent, FDPS inhibitor
CAS 138926-19-9
MW: 359.2 D
From 55.00€ *
Review
Ibandronate Sodium Monohydrate
Ibandronate Sodium Monohydrate

Item number: LKT-I0502.10

Bisphosphonate.
Keywords: Ibandronic acid sodium salt, [1-Hydroxy-3-(methylpentylamino)propylidene]bis- phosphonic acid
Application: Farnesylpyrophosphate synthetase inhibitor
CAS 138926-19-9
MW: 359.21 D
From 177.00€ *
Review